Co-catalpol alleviates fluoxetine-induced main toxicity: Involvement of ATF3/FSP1 signaling-mediated inhibition of ferroptosis.
Wu X, Guan Y, Wang J, Song L, Zhang Y, Wang Y, Li Y, Qin L, He Q, Zhang T, Long B, Ji L.
Phytomedicine. 2024 Apr;126:155340. doi: 10.1016/j.phymed.2024.155340. Epub 2024 Feb 5.
Fluoxetine induced dyskinesia.
Mander A, McCausland M, Workman B, Flamer H, Christophidis N.
Aust N Z J Psychiatry. 1994 Jun;28(2):328-30. doi: 10.1080/00048679409075647.
Safety of antidepressants.
Swinkels JA, de Jonghe F.
Int Clin Psychopharmacol. 1995 Jan;9 Suppl 4:19-25. doi: 10.1097/00004850-199501004-00003.
Fluoxetine overdose.
Finnegan KT, Gabiola JM.
Am J Psychiatry. 1988 Dec;145(12):1604. doi: 10.1176/ajp.145.12.1604b.
The safety of fluoxetine--an update.
Cooper GL.
Br J Psychiatry Suppl. 1988 Sep;(3):77-86.
Fluoxetine-induced Stevens-Johnson syndrome and liver injury.
Agrawal R, Almoghrabi A, Attar BM, Gandhi S.
J Clin Pharm Ther. 2019 Feb;44(1):115-118. doi: 10.1111/jcpt.12760. Epub 2018 Oct 8.
Alcoholism.
Bohn MJ.
Psychiatr Clin North Am. 1993 Dec;16(4):679-92.
The serotonin syndrome.
Sternbach H.
Am J Psychiatry. 1991 Jun;148(6):705-13. doi: 10.1176/ajp.148.6.705.
Fluoxetine overdose: a case report.
Rohrig TP, Prouty RW.
J Anal Toxicol. 1989 Sep-Oct;13(5):305-7. doi: 10.1093/jat/13.5.305.
Laryngeal dystonia.
Murray V.
Br J Psychiatry. 1995 Nov;167(5):698-9. doi: 10.1192/bjp.167.5.698b.
